Taking cancer research from lab to patients

(Photo: Colourbox)

The Technology Transfer Office in Bergen was instrumental when a cancer test developed by Norwegian researchers was made available to US physicians in August 2010.

Cancer researchers in Bergen have helped to develop a new technology that could customise and improve the treatment of endometrial (uterine) cancer patients. Bergen Teknologioverføring (BTO), a company specialised in commercialising research results, helped the researchers to get their licensing structure in place.

“It is a good feeling to help along such important research that can benefit society,” says Berit Bjørnhaug, a legal adviser at BTO.

Latest inside news